Relay Therapeutics Statistics
NASDAQ: RLAYHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
17.95-0.79 (-4.22%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Relay Therapeutics by the numbers
Relay Therapeutics has a market capitalization of $3.93 billion based on 219.14M shares outstanding. With trailing EPS of $-1.56, Relay Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.1% below its 50-day average and 27.2% above its 200-day average.
Average daily trading volume is 2.81M shares, or about $50.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RLAY valuation vs. peer median
| Metric | RLAY | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.93B | $3.82B | +3% |
| Avg. volume | 2.81M | 1.60M | +76% |
Peer median across 8 companies: ADPT, TARS, DNLI, CRSP, SRRK, BEAM, CGON, RXRX.
Valuation
- Market cap
- $3.93B
- Price / sales (latest FY)
- 256.18
- EPS (TTM)
- $-1.56
- Shares outstanding
- 219.14M
Price and trading
- Previous close
- 18.74
- Open
- 18.40
- Day range
- 17.85 – 18.48
- 52-week range
- 5.83 – 21.27
- 52-week change
- +207.89%
- Beta
- —
- Volume
- 3.43M
- Average volume
- 2.81M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 3.93B
- Forward Pe
- -11.00
- Eps
- -1.56
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 21.27
- Week52 Low
- 5.83
- Avg Volume
- 2.81M
- Shares Outstanding
- 219.14M
- Ma50
- 19.11
- Ma200
- 14.12
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -15.61%
- Pct From52w Low
- 207.89%